Literature DB >> 9153706

Biphasic contrast-enhanced multisection dynamic MR imaging of the liver: potential pitfalls.

K Ito1, D G Mitchell, K Honjo, T Fujita, H Awaya, T Matsumoto, N Matsunaga.   

Abstract

Biphasic contrast material-enhanced dynamic magnetic resonance (MR) imaging is an important technique for evaluating liver disease. However, several potential diagnostic pitfalls may be encountered, including lobar, segmental, subsegmental, and subcapsular hyperperfusion abnormalities; early-enhancing pseudolesions, particularly in the medial segment of the left hepatic lobe; heterogeneous hyperperfusion abnormalities throughout the liver; and hypointense pseudolesions due to vascular artifacts, unenhanced hepatic vessels, partial volume artifacts, magnetic susceptibility artifacts, and regenerative nodules in cirrhosis. These abnormalities sometimes have appearances similar to those of true lesions or tumor spread to the surrounding liver parenchyma on arterial-dominant phase dynamic MR images. In most cases, however, no corresponding abnormalities are seen with other pulse sequences or on delayed-phase MR images. In addition, hyperperfusion abnormalities due to readily recognizable causes are often found in characteristic locations and thus can be differentiated from true tumors. An understanding of the causes of these potential pitfalls and how to avoid them will help radiologists understand and correctly interpret images.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153706     DOI: 10.1148/radiographics.17.3.9153706

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  1 in total

1.  Thioguanin-induced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques.

Authors:  Christoph J Zech; Julia Seiderer; Walter Reinisch; Thomas Ochsenkuhn; Wolfgang Schima; Joachim Diebold; Fritz Wrba; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Eur Radiol       Date:  2007-01-13       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.